SEC Form 4 · accession 0001562180-18-002455
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman David Eansor
Officer — SVP - Novus Biologicals
Period of report
May 4, 2018
Accepted (ET)
May 11, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2018 | S | 1,136 | $145.1864 | D | 2,266 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | holding | — | — | — | — | — | Common Stock | 1,500 | 1,500 | D |
| Restricted Stock UnitsF1,F3 | — | holding | — | — | — | — | — | Common Stock | 2,287 | 2,287 | D |
| Restricted Stock UnitsF1,F4 | — | holding | — | — | — | — | — | Common Stock | 2,174 | 2,174 | D |
| Stock Option (Right to Buy)F5 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 12,500 | 12,500 | D |
| Stock Option (Right to Buy)F2 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 9,375 | 9,375 | D |
| Stock Option (Right to Buy)F6 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 15,000 | 15,000 | D |
| Stock Options (Right to buy)F4 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 11,982 | 11,982 | D |
| Stock Options (Right to buy)F7 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 15,976 | 15,976 | D |
| Stock Options (Right to buy)F8 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 18,819 | 18,819 | D |
| Stock Options (Right to buy)F3 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 14,114 | 14,114 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F2Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F3Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F4Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F53,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F63,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
- F7Vest 3,994 shares on each 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021
- F8Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.